{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,18]],"date-time":"2026-10-18T04:25:14Z","timestamp":1792297514293,"version":"4.4.0"},"reference-count":41,"publisher":"Frontiers Media SA","license":[{"start":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T00:00:00Z","timestamp":1778198400000},"content-version":"vor","delay-in-days":0,"URL":"https:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"content-domain":{"domain":["frontiersin.org"],"crossmark-restriction":true},"short-container-title":["Front. Oncol."],"abstract":"<jats:sec>\n                    <jats:title>Introduction<\/jats:title>\n                    <jats:p>Discovery of biomarkers predictive of endotheliopathy after hematopoietic stem cell transplant (HSCT) has the potential to more rapidly identify vulnerable patients, guide treatment decisions, track responses to therapy, and inform targets for novel treatment. This study aimed to evaluate the levels and predictive capabilities of glycocalyx biomarkers for endotheliopathy in the first 100 days following HSCT in pediatric and young adult patients.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Methods<\/jats:title>\n                    <jats:p>Parallel prospective observational pilot studies were performed to examine markers related to endothelial glycocalyx structure, function, and regulation at St. Jude Children\u2019s Research Hospital (SJCRH) and MD Anderson Cancer Center (MDACC). The MDACC study took a discovery-driven approach using a 55-biomarker panel performed at two early timepoints whereas the SJCRH study adopted a targeted approach evaluating a 6-biomarker panel at eight scheduled timepoints. Biomarker levels in patients\u2019 post-HSCT who did or did not develop endotheliopathy were compared at specific timepoints predicative value was assessed using Area Under the Curve (AUC) and Youden Index.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>In the SJCRH study, Syndecan-1 and Angiopoietin-2 levels were found to be significantly different between cases of endotheliopathy and controls at multiple time points. Predictive values for both were good to excellent when comparing the time-point immediately before diagnosis of endotheliopathy in cases to standardized time-points of Days 7, 14, and 21 in controls. This was noted for endotheliopathy in general as well for sinusoidal obstruction syndrome (SOS)\/veno-occlusive disease (VOD) or transplant-associated thrombotic microangiopathy (TA-TMA). In the MDACC study, a signature of markers was found to be associated with endotheliopathy on Days 0 and 7. Specifically, Tissue inhibitor of metalloproteinases-1 (TIMP-1) and insulin-like growth factor-binding protein-3 (IGFBP-3) had perfect performance (AUC of 1) for endotheliopathy.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Discussion<\/jats:title>\n                    <jats:p>Biomarkers of glycocalyx damage and dysregulation have significant potential to predict endotheliopathy in pediatric and young adult patients undergoing HSCT. The convergence of these two studies, one targeted and one unbiased, affirms the central role of endothelial injury in post-HSCT complications and provides a list of potential candidate predictors. Given small sample size and hence limited generalizability, further research is required to validate these findings in larger patient cohorts.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.3389\/fonc.2026.1789000","type":"journal-article","created":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:35:10Z","timestamp":1778214910000},"update-policy":"https:\/\/doi.org\/10.3389\/crossmark-policy","source":"Crossref","is-referenced-by-count":1,"title":["Glycocalyx biomarkers as early predictors of endotheliopathy in pediatric and young adult hematopoietic stem cell transplantation patients"],"prefix":"10.3389","volume":"16","author":[{"given":"Kimberly","family":"Uchida","sequence":"first","affiliation":[{"name":"Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]},{"name":"Department of Pediatrics, Division of Pediatric Critical Care Medicine, The University of Tennessee Health Science Center","place":["Memphis, TN, United States"]},{"name":"Department of Pediatrics, Division of Pediatric Critical Care, University of Utah Health","place":["Salt Lake, UT, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kris M","family":"Mahadeo","sequence":"additional","affiliation":[{"name":"Department of Pediatrics, Division of Pediatric Transplantation and Cellular Therapy, Duke University","place":["Durham, NC, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jennifer","family":"McArthur","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]},{"name":"Department of Pediatrics, Division of Pediatric Critical Care Medicine, The University of Tennessee Health Science Center","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yvonne","family":"Avent","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chia-Wei","family":"Hsu","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St. Jude Children's Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haitao","family":"Pan","sequence":"additional","affiliation":[{"name":"Department of Biostatistics, St. Jude Children's Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lama","family":"Elbahlawan","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Melissa","family":"Hines","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Akshay","family":"Sharma","sequence":"additional","affiliation":[{"name":"Department of Bone Marrow Transplantation & Cellular Therapy, St. Jude Children's Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ruth G.","family":"Tatevossian","sequence":"additional","affiliation":[{"name":"Clinical Biomarkers Laboratory, Department of Pathology, St. Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Sebabrata","family":"Mahapatra","sequence":"additional","affiliation":[{"name":"Clinical Biomarkers Laboratory, Department of Pathology, St. Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Meenasri","family":"Kumbaji","sequence":"additional","affiliation":[{"name":"Clinical Biomarkers Laboratory, Department of Pathology, St. Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Irtiza","family":"Sheikh","sequence":"additional","affiliation":[{"name":"Department of Stem Cell Transplantation, Division of Pediatrics, The University of Texas MD Anderson Cancer Center","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Ying","family":"Li","sequence":"additional","affiliation":[{"name":"Department of Bone Marrow Transplantation & Cellular Therapy, St. Jude Children's Research Hospital","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Keri","family":"Schadler","sequence":"additional","affiliation":[{"name":"Department of Pediatrics Research, Division of Pediatrics, The University of Texas MD Anderson Cancer Center","place":["Houston, TX, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Saad","family":"Ghafoor","sequence":"additional","affiliation":[{"name":"Department of Pediatric Medicine, Division of Critical Care Medicine, St. Jude Children\u2019s Research Hospital","place":["Memphis, TN, United States"]},{"name":"Department of Pediatrics, Division of Pediatric Critical Care Medicine, The University of Tennessee Health Science Center","place":["Memphis, TN, United States"]}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"1965","published-online":{"date-parts":[[2026,5,8]]},"reference":[{"key":"B1","doi-asserted-by":"publisher","DOI":"10.1097\/CCM.0000000000001085","article-title":"New insights into multicenter PICU mortality among pediatric hematopoietic stem cell transplant patients","volume":"43","author":"Zinter","year":"2015","journal-title":"Crit Care Med"},{"key":"B2","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2021.622630","article-title":"Perspective: a framework to screen pediatric and adolescent hematopoietic cellular therapy patients for organ dysfunction: time for a multi-disciplinary and longitudinal approach","volume":"11","author":"Ahmad","year":"2021","journal-title":"Front Oncol"},{"key":"B3","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2011.65","article-title":"The role of the endothelium in the short-term complications of hematopoietic SCT","volume":"46","author":"Carreras","year":"2011","journal-title":"Bone Marrow Transplant"},{"key":"B4","doi-asserted-by":"publisher","DOI":"10.1182\/bloodadvances.2019000143","article-title":"Allogeneic reactivity\u2013mediated endothelial cell complications after HSCT: a plea for consensual definitions","volume":"3","author":"Pagliuca","year":"2019","journal-title":"Blood Adv"},{"key":"B5","doi-asserted-by":"publisher","first-page":"23","DOI":"10.1016\/j.bbmt.2007.10.008","article-title":"The contribution of endothelial activation and injury to end-organ toxicity following allogeneic hematopoietic stem cell transplantation","volume":"14","author":"Cooke","year":"2008","journal-title":"Biol Blood Marrow Transplant"},{"key":"B6","doi-asserted-by":"publisher","DOI":"10.1111\/bjh.16621","article-title":"Endothelial cell function and endothelial\u2010related disorders following haematopoietic cell transplantation","volume":"190","author":"Hildebrandt","year":"2020","journal-title":"Br J Haematol"},{"key":"B7","doi-asserted-by":"publisher","DOI":"10.1038\/s41409-021-01390-y","article-title":"Endothelial cell dysfunction: a key determinant for the outcome of allogeneic stem cell transplantation","volume":"56","author":"Luft","year":"2021","journal-title":"Bone Marrow Transplant"},{"key":"B8","doi-asserted-by":"publisher","first-page":"S97","DOI":"10.1542\/peds.2021-052888O","article-title":"Endothelial dysfunction criteria in critically ill children: the PODIUM consensus conference","volume":"149","author":"Pierce","year":"2022","journal-title":"Pediatrics"},{"key":"B9","doi-asserted-by":"publisher","DOI":"10.1542\/peds.2017-0355","article-title":"Endothelial cell function and dysfunction in critically ill children","volume":"140","author":"Pierce","year":"2017","journal-title":"Pediatrics"},{"key":"B10","doi-asserted-by":"publisher","DOI":"10.3389\/fimmu.2021.641427","article-title":"Biomarkers for early complications of endothelial origin after allogeneic hematopoietic stem cell transplantation: do they have a potential clinical role","volume":"12","author":"Lia","year":"2021","journal-title":"Front Immunol"},{"key":"B11","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2019.09.027","article-title":"Comprehensive prognostication in critically ill pediatric hematopoietic cell transplant patients: results from merging the Center for International Blood and Marrow Transplant Research (CIBMTR) and Virtual Pediatric Systems (VPS) registries","volume":"26","author":"Zinter","year":"2020","journal-title":"Biol Blood Marrow Transplant"},{"key":"B12","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2010.02.008","article-title":"Endothelial dysfunction after hematopoietic stem cell transplantation: role of the conditioning regimen and the type of transplantation","volume":"16","author":"Palomo","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B13","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.143","article-title":"Biomarkers for acute GVHD: can we predict the unpredictable","volume":"48","author":"Chen","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B14","doi-asserted-by":"publisher","first-page":"16","DOI":"10.1186\/s13054-018-2292-6","article-title":"The glycocalyx: a novel diagnostic and therapeutic target in sepsis","volume":"23","author":"Uchimido","year":"2019","journal-title":"Crit Care"},{"key":"B15","doi-asserted-by":"crossref","DOI":"10.1002\/cphy.c210029","article-title":"Endothelial glycocalyx","volume-title":"Comprehensive physiology","author":"Foote","year":"2022"},{"key":"B16","doi-asserted-by":"publisher","DOI":"10.1007\/s00424-007-0212-8","article-title":"The endothelial glycocalyx: composition, functions, and visualization","volume":"454","author":"Reitsma","year":"2007","journal-title":"Pfl\u00fcg Arch - Eur J Physiol"},{"key":"B17","doi-asserted-by":"publisher","DOI":"10.1097\/01.TP.0000074316.76104.A5","article-title":"Increased levels of syndecan-1 in serum during acute graft-versus-host disease","volume":"76","author":"Seidel","year":"2003","journal-title":"Transplantation"},{"key":"B18","doi-asserted-by":"publisher","DOI":"10.1111\/anae.12661","article-title":"The endothelial glycocalyx: a review of the vascular barrier","volume":"69","author":"Alphonsus","year":"2014","journal-title":"Anaesthesia"},{"key":"B19","doi-asserted-by":"publisher","DOI":"10.1146\/annurev.bioeng.9.060906.151959","article-title":"The structure and function of the endothelial glycocalyx layer","volume":"9","author":"Weinbaum","year":"2007","journal-title":"Annu Rev BioMed Eng"},{"key":"B20","doi-asserted-by":"publisher","DOI":"10.1093\/cvr\/cvx023","article-title":"Endothelial glycocalyx breakdown is mediated by angiopoietin-2","volume":"113","author":"Lukasz","year":"2017","journal-title":"Cardiovasc Res"},{"key":"B21","doi-asserted-by":"publisher","DOI":"10.3390\/cells8050471","article-title":"Role of angiopoietin-2 in vascular physiology and pathophysiology","volume":"8","author":"Akwii","year":"2019","journal-title":"Cells"},{"key":"B22","doi-asserted-by":"publisher","DOI":"10.7150\/jca.100612","article-title":"Intercellular adhesion molecule 3: structure, cellular functions, and emerging role in human diseases","volume":"16","author":"Shen","year":"2025","journal-title":"J Cancer"},{"key":"B23","doi-asserted-by":"publisher","DOI":"10.1084\/jem.175.1.185","article-title":"Intercellular adhesion molecule 3, a third adhesion counter-receptor for lymphocyte function-associated molecule 1 on resting lymphocytes","volume":"175","author":"de Fougerolles","year":"1992","journal-title":"J Exp Med"},{"key":"B24","doi-asserted-by":"crossref","DOI":"10.1007\/978-3-030-02278-5","volume-title":"The EBMT handbook: hematopoietic stem cell transplantation and cellular therapies","author":"Carreras","year":"2019"},{"key":"B25","doi-asserted-by":"publisher","DOI":"10.1016\/S2352-3026(19)30201-7","article-title":"Diagnosis, grading, and treatment recommendations for children, adolescents, and young adults with sinusoidal obstructive syndrome: an international expert position statement","volume":"7","author":"Mahadeo","year":"2020","journal-title":"Lancet Haematol"},{"key":"B26","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2014-03-564997","article-title":"Diagnostic and risk criteria for HSCT-associated thrombotic microangiopathy: a study in children and young adults","volume":"124","author":"Jodele","year":"2014","journal-title":"Blood"},{"key":"B27","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2017.161","article-title":"Diagnosis and severity criteria for sinusoidal obstruction syndrome\/veno-occlusive disease in pediatric patients: a new classification from the European society for blood and marrow transplantation","volume":"53","author":"Corbacioglu","year":"2018","journal-title":"Bone Marrow Transplant"},{"key":"B28","doi-asserted-by":"publisher","DOI":"10.1016\/S0140-6736(11)61938-7","article-title":"Defibrotide for prophylaxis of hepatic veno-occlusive disease in paediatric haemopoietic stem-cell transplantation: an open-label, phase 3, randomised controlled trial","volume":"379","author":"Corbacioglu","year":"2012","journal-title":"Lancet"},{"key":"B29","doi-asserted-by":"publisher","DOI":"10.1182\/blood-2015-10-676924","article-title":"Phase 3 trial of defibrotide for the treatment of severe veno-occlusive disease and multi-organ failure","volume":"127","author":"Richardson","year":"2016","journal-title":"Blood"},{"key":"B30","doi-asserted-by":"publisher","DOI":"10.3389\/fonc.2025.1642939","article-title":"Endotheliopathy syndromes, TA-TMA, and SOS, are risk factors for morbidity and mortality in critically ill pediatric hematopoietic cell transplant recipients","volume":"15","author":"Goel","year":"2025","journal-title":"Front Oncol"},{"key":"B31","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2009.08.024","article-title":"Hepatic veno-occlusive disease following stem cell transplantation: incidence, clinical course, and outcome","volume":"16","author":"Coppell","year":"2010","journal-title":"Biol Blood Marrow Transplant"},{"key":"B32","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2019004218","article-title":"Complement blockade for TA-TMA: lessons learned from a large pediatric cohort treated with eculizumab","volume":"135","author":"Jodele","year":"2020","journal-title":"Blood"},{"key":"B33","doi-asserted-by":"publisher","DOI":"10.1182\/blood.2023022526","article-title":"A prospective multi-institutional study of eculizumab to treat high-risk stem cell transplantation\u2013associated TMA","volume":"143","author":"Jodele","year":"2024","journal-title":"Blood"},{"key":"B34","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.31943","article-title":"Syndecan\u20101 is associated with sinusoidal obstruction syndrome and severe acute graft\u2010versus\u2010host disease after pediatric hematopoietic stem cell transplantation","volume":"72","author":"Horan","year":"2025","journal-title":"Pediatr Blood Cancer"},{"key":"B35","doi-asserted-by":"publisher","DOI":"10.1080\/1354750X.2020.1787518","article-title":"Glycocalyx damage biomarkers in healthy controls, abdominal surgery, and sepsis: a scoping review","volume":"25","author":"Yanase","year":"2020","journal-title":"Biomarkers"},{"key":"B36","doi-asserted-by":"publisher","DOI":"10.1038\/bmt.2012.101","article-title":"Higher angiopoietin-2 and VEGF levels predict shorter EFS and increased non-relapse mortality after pediatric hematopoietic SCT","volume":"48","author":"Porkholm","year":"2013","journal-title":"Bone Marrow Transplant"},{"key":"B37","doi-asserted-by":"publisher","DOI":"10.3390\/ijms24086960","article-title":"Endothelial injury syndromes after allogeneic hematopoietic stem cell transplantation: angiopetin-2 as a novel predictor of the outcome and the role of functional autoantibodies against angiotensin II type 1 and endothelin A receptor","volume":"24","author":"Vythoulkas","year":"2023","journal-title":"Int J Mol Sci"},{"key":"B38","doi-asserted-by":"publisher","DOI":"10.1016\/j.bbmt.2014.04.030","article-title":"Predictive value of circulating angiopoietin-2 for endothelial damage\u2013related complications in allogeneic hematopoietic stem cell transplantation","volume":"20","author":"Ueda","year":"2014","journal-title":"Biol Blood Marrow Transplant"},{"key":"B39","doi-asserted-by":"publisher","DOI":"10.1111\/ejh.12990","article-title":"Study of bone metabolism and angiogenesis in patients undergoing high\u2010dose chemotherapy\/autologous hematopoietic stem cell transplantation","volume":"100","author":"Boutsikas","year":"2018","journal-title":"Eur J Haematol"},{"key":"B40","doi-asserted-by":"publisher","DOI":"10.3390\/ijms21249739","article-title":"The roles of matrix metalloproteinases and their inhibitors in human diseases","volume":"21","author":"Cabral-Pacheco","year":"2020","journal-title":"Int J Mol Sci"},{"key":"B41","doi-asserted-by":"publisher","DOI":"10.1210\/er.2008-0028","article-title":"Unraveling insulin-like growth factor binding protein-3 actions in human disease","volume":"30","author":"Jogie-Brahim","year":"2009","journal-title":"Endocr Rev"}],"container-title":["Frontiers in Oncology"],"original-title":[],"link":[{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1789000\/full","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2026,5,8]],"date-time":"2026-05-08T04:35:18Z","timestamp":1778214918000},"score":1,"resource":{"primary":{"URL":"https:\/\/www.frontiersin.org\/articles\/10.3389\/fonc.2026.1789000\/full"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,5,8]]},"references-count":41,"alternative-id":["10.3389\/fonc.2026.1789000"],"URL":"https:\/\/doi.org\/10.3389\/fonc.2026.1789000","relation":{},"ISSN":["2234-943X"],"issn-type":[{"value":"2234-943X","type":"electronic"}],"subject":[],"published":{"date-parts":[[2026,5,8]]},"article-number":"1789000"}}